Desogestrel Contraceptives: 1.6 Million French Women Warned of Tumour Risk
22 Articles
22 Articles
Notice to 1.6 million women who have taken the pill for “very weak risk” of developing meningioma
The 75 μg deogestrel-based pills present a low risk of tumours in the brain. 1.6 million French people who have used these pills will receive a letter from the National Drug Security Agency...
Desogestrel contraceptives: 1.6 million French women warned of tumour risk
The French medicines agency (ANSM) urges women who take desogestrel contraceptives to seek medical advice if they develop suggestive symptoms, such as persistent headaches, visual disturbances or memory loss.
This concerns degestrel-based contraceptives such as Antigone, Cerazette, Elfasette, Optimizette pills...
Women who have taken pills such as Antigone, Cerazette, Elfasette or Optimizette are affected. L的ANSM recommends that they consult in case of symptoms.
The National Medicines Security Agency (ANSM) will alert 1.6 million women about a risk of meningioma, a benign brain tumour. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .…
Coverage Details
Bias Distribution
- 46% of the sources lean Left, 46% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
